These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 26971226)

  • 1. Role of PHLPP1 in inflammation response: Its loss contributes to gliomas development and progression.
    Teng DC; Sun J; An YQ; Hu ZH; Liu P; Ma YC; Han B; Shi Y
    Int Immunopharmacol; 2016 May; 34():229-234. PubMed ID: 26971226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant expression of PHLPP1 and PHLPP2 correlates with poor prognosis in patients with hypopharyngeal squamous cell carcinoma.
    Zhou J; Yu X; Wang J; Li T; Jin T; Lei D; Pan X
    PLoS One; 2015; 10(3):e0119405. PubMed ID: 25793736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic suppression of PHLPP1 in human melanoma.
    Dong L; Jin L; Tseng HY; Wang CY; Wilmott JS; Yosufi B; Yan XG; Jiang CC; Scolyer RA; Zhang XD; Guo ST
    Oncogene; 2014 Sep; 33(39):4756-66. PubMed ID: 24121273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WD repeat protein WDR48 in complex with deubiquitinase USP12 suppresses Akt-dependent cell survival signaling by stabilizing PH domain leucine-rich repeat protein phosphatase 1 (PHLPP1).
    Gangula NR; Maddika S
    J Biol Chem; 2013 Nov; 288(48):34545-54. PubMed ID: 24145035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PHLPPing through history: a decade in the life of PHLPP phosphatases.
    Grzechnik AT; Newton AC
    Biochem Soc Trans; 2016 Dec; 44(6):1675-1682. PubMed ID: 27913677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel immunomodulatory function of PHLPP1: inhibition of iNOS via attenuation of STAT1 ser727 phosphorylation in mouse macrophages.
    Alamuru NP; Behera S; Butchar JP; Tridandapani S; Kaimal Suraj S; Babu PP; Hasnain SE; Ehtesham NZ; Parsa KV
    J Leukoc Biol; 2014 May; 95(5):775-783. PubMed ID: 24443556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-522 contributes to cell proliferation of human glioblastoma cells by suppressing PHLPP1 expression.
    Zhang S; Zhang H; Zhu J; Zhang X; Liu Y
    Biomed Pharmacother; 2015 Mar; 70():164-9. PubMed ID: 25776496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scribble-mediated membrane targeting of PHLPP1 is required for its negative regulation of Akt.
    Li X; Yang H; Liu J; Schmidt MD; Gao T
    EMBO Rep; 2011 Jun; 12(8):818-24. PubMed ID: 21701506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleckstrin Homology Domain Leucine-rich Repeat Protein Phosphatase Acts as a Tumor Suppressor in Oral Squamous Cell Carcinoma.
    Etemad-Moghadam S; Mohammadpour H; Emami Razavi A; Alaeddini M
    Appl Immunohistochem Mol Morphol; 2024 May-Jun 01; 32(5):249-253. PubMed ID: 38602289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant expression of interleukin-1β and inflammasome activation in human malignant gliomas.
    Tarassishin L; Casper D; Lee SC
    PLoS One; 2014; 9(7):e103432. PubMed ID: 25054228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein phosphatase 4 catalytic subunit is overexpressed in glioma and promotes glioma cell proliferation and invasion.
    Li M; Li X; Xu S; Xue P; Li Q; Lu Q; Jia Q; Zhang L; Li X; Li X
    Tumour Biol; 2016 Sep; 37(9):11893-11901. PubMed ID: 27059736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PHLPP Signaling in Immune Cells.
    Lordén G; Lam AJ; Levings MK; Newton AC
    Curr Top Microbiol Immunol; 2022; 436():117-143. PubMed ID: 36243842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. USP1 regulates AKT phosphorylation by modulating the stability of PHLPP1 in lung cancer cells.
    Zhiqiang Z; Qinghui Y; Yongqiang Z; Jian Z; Xin Z; Haiying M; Yuepeng G
    J Cancer Res Clin Oncol; 2012 Jul; 138(7):1231-8. PubMed ID: 22426999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of phosphatase PHLPP1 gene transfer on the proliferation of human umbilical vein endothelial cells].
    Wu XL; Yang DY; Yan W; Shang AJ; Lu CY; Xu HB; Wang SW
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun; 30(6):1298-300. PubMed ID: 20584661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced expression of the tumor suppressor PHLPP1 enhances the antiapoptotic B-cell receptor signal in chronic lymphocytic leukemia B-cells.
    Suljagic M; Laurenti L; Tarnani M; Alam M; Malek SN; Efremov DG
    Leukemia; 2010 Dec; 24(12):2063-71. PubMed ID: 20861921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eukaryotic initiation factor 3C silencing inhibits cell proliferation and promotes apoptosis in human glioma.
    Hao J; Wang Z; Wang Y; Liang Z; Zhang X; Zhao Z; Jiao B
    Oncol Rep; 2015 Jun; 33(6):2954-62. PubMed ID: 25823503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of PHLPP1α/β in human and mouse brain by different anti-PHLPP1 antibodies.
    Jackson TC; Bayir H; Ikonomovic MD; Janesko-Feldman K; Mi Z; Gao T; Jackson EK; Kochanek PM
    Sci Rep; 2015 Apr; 5():9377. PubMed ID: 25827478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Over-expression of wild-type p53-induced phosphatase 1 confers poor prognosis of patients with gliomas.
    Liang C; Guo E; Lu S; Wang S; Kang C; Chang L; Liu L; Zhang G; Wu Z; Zhao Z; Ma S; Wang L; Jiao BH
    Brain Res; 2012 Mar; 1444():65-75. PubMed ID: 22325093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PHLPP1 mediates melanoma metastasis suppression through repressing AKT2 activation.
    Yu Y; Dai M; Lu A; Yu E; Merlino G
    Oncogene; 2018 Apr; 37(17):2225-2236. PubMed ID: 29391600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients.
    Homma J; Yamanaka R; Yajima N; Tsuchiya N; Genkai N; Sano M; Tanaka R
    Oncol Rep; 2006 Mar; 15(3):595-601. PubMed ID: 16465418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.